McKesson Corporation logo

McKesson Corporation (MCK)

Market Closed
14 Oct, 03:31 PM
XETRA XETRA
€
875. 60
+15.8
+1.8376%
€
- Market Cap
17.39 P/E Ratio
3.28% Div Yield
40 Volume
25.95 Eps
€ 859.8
Previous Close
Add Transaction
Day Range
860.6 878.2
Year Range
655.8 878.2
Want to track MCK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MCK closed yesterday higher at €875.6, an increase of 1.8376% from Tuesday's close, completing a monthly increase of 15.9735% or €120.6. Over the past 12 months, MCK stock gained 31.1171%.
MCK pays dividends to its shareholders, with the most recent payment made on Oct 01, 2026. The next estimated payment will be in In 2 months on Jan 01, 2027 for a total of €0.94.
The last earnings report, released on May 13, 2026, missed the consensus estimates by -11.37%. On average, the company has fell short of earnings expectations by -6.68%, based on the last three reports.
McKesson Corporation has completed 1 stock splits, with the recent split occurring on Jan 05, 1998.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on NYSE (USD).

MCK Chart

McKesson (MCK) Ascends While Market Falls: Some Facts to Note

McKesson (MCK) Ascends While Market Falls: Some Facts to Note

McKesson (MCK) reached $976.57 at the closing of the latest trading day, reflecting a +1.53% change compared to its last close.

Zacks | 23 hours ago
McKesson (MCK) is a Top-Ranked Value Stock: Should You Buy?

McKesson (MCK) is a Top-Ranked Value Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 2 days ago
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term

Why McKesson (MCK) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 6 days ago

McKesson Corporation (MCK) FAQ

What is the stock price today?

The current price is €875.60.

On which exchange is it traded?

McKesson Corporation is listed on XETRA.

What is its stock symbol?

The ticker symbol is MCK.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 3.28%.

What is its market cap?

As of today, no market cap data is available.

Has McKesson Corporation ever had a stock split?

McKesson Corporation had 1 splits and the recent split was on Jan 05, 1998.

McKesson Corporation Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Brian S. Tyler CEO
XETRA Exchange
US58155Q1031 ISIN
US Country
42,300 Employees
1 Sep 2026 Last Dividend
5 Jan 1998 Last Split
15 Nov 1994 IPO Date

Overview

McKesson Corporation stands as a prominent provider of healthcare services not only within the United States but also on an international platform. With its foundation laid in 1833, the company has excelled in extending its footprint across various segments of the healthcare industry, making it headquartered in Irving, Texas. Operating through four main segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International, McKesson strives to address the variegated needs of the healthcare realm. These segments collaborate to distribute pharmaceuticals, offer technological and clinical solutions, and ensure necessary medical supplies reach healthcare providers efficiently.

Products and Services

  • U.S. Pharmaceutical:
  • This segment is instrumental in distributing a vast array of pharmaceuticals, including branded, generic, specialty, biosimilar, and over-the-counter drugs. Furthermore, it caters to community-based oncology and other specialty practices by supplying practice management, technology, clinical support, and business solutions. Additionally, it encompasses services like consulting, outsourcing, technological offerings, and providing financial, operational, and clinical solutions targeted at pharmacies.

  • Prescription Technology Solutions (RxTS):
  • Under this banner, McKesson takes a significant step towards bridging the medication-related gaps between biopharma, life sciences partners, and patients by interlinking patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. The RxTS segment aims at rolling out innovative solutions to streamline the process of medication acquisition, ensuring the delivery of medicine that enriches patient health. Services rendered include prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support.

  • Medical-Surgical Solutions:
  • This segment ensures the streamlined distribution of medical and surgical supplies, logistics, and other pivotal services to various healthcare settings, encompassing physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. It represents McKesson's commitment to providing essential supplies and services that support the health ecosystem's backbone, thereby enabling healthcare providers to deliver quality care.

  • International:
  • McKesson's International segment focuses on the distribution of pharmaceuticals and medical supplies, along with rendering services to a vast customer base, including wholesale, institutional, and retail channels across Europe and Canada. This segment showcases the company's dedication to extending its healthcare services and products to a global audience, ensuring an international footprint in healthcare distribution and services.

Contact Information

Address: 6555 State Highway 161
Phone: 972 446 4800